Basic Information

Gene symbol CD276 Synonyms 4Ig-B7-H3, B7-H3, B7H3, B7RP-2 Type of gene protein-coding
Description CD276 molecule

GTO ID GTC2936
Trial ID NCT05241392
Disease Glioblastoma
Altered gene CD276
Therapeutic/Target gene Target gene
TherapyCAR-T cell
Treatment B7-H3 CAR-T cells
PhasePhase1
Recruitment statusRecruiting
TitleSafety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
Year2022
CountryChina
Company sponsorBeijing Tiantan Hospital
Other ID(s)TE3T-IG005

Clinical Result

Cohort1: dose level 1
Administration route intracranial infusion
Dosage 2E7 cells/cycle
Donor type Autologous
Pts 3
Age Adult, Older_Adult
Cohort2: dose level 2
Administration route intracranial infusion
Dosage 6E7 cells/cycle
Donor type Autologous
Pts 3
Age Adult, Older_Adult
Cohort3: dose level 3
Administration route intracranial infusion
Dosage 1.5E8 cells/cycle
Donor type Autologous
Pts 3
Age Adult, Older_Adult
Cohort4: dose level 4
Administration route intracranial infusion
Dosage 4.5E8 cells/cycle
Donor type Autologous
Pts 3
Age Adult, Older_Adult
Cohort5: dose level 5
Administration route intracranial infusion
Dosage 9E8 cells/cycle
Donor type Autologous
Pts 3
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph